154 related articles for article (PubMed ID: 5346780)
1. [Activation of euglobulin lysis induced by Atheroid (R)].
Prino G; Mantovani M; Butti A
Boll Soc Ital Biol Sper; 1969 Jan; 45(2):133-7. PubMed ID: 5346780
[No Abstract] [Full Text] [Related]
2. [Use of the thromboelastograph for registration of the time of euglobulin lysis in normal rats and those with experimentally modified fibrinolysis].
Prino G; Mantovani M; Butti A
Farmaco Prat; 1969 Sep; 24(9):552-61. PubMed ID: 4187112
[No Abstract] [Full Text] [Related]
3. [Effect of actomyosin on blood coagulation and fibrinolysis].
Andreenko GV; Liutova LV
Vopr Med Khim; 1976; 22(2):166-71. PubMed ID: 1030884
[TBL] [Abstract][Full Text] [Related]
4. [Studies in the benzofuran series. LV. Fibrinolytic properties of inicarone].
Barchewitz G; Brotelle R; Guilbert A; Charlier R
Therapie; 1974; 29(1):57-70 passim. PubMed ID: 4849779
[No Abstract] [Full Text] [Related]
5. [On the difference between serum and euglobulin in determination of fibrinolytic activities by streptokinase-activated method with special reference to the relationship with antiplasmin agents].
Miyatani K; Fukui I
Rinsho Byori; 1971 Mar; 19(3):223-6. PubMed ID: 4252723
[No Abstract] [Full Text] [Related]
6. Fibrinolysis in the rat after short-term aspirin therapy.
Housholder GT; Moorrees LL
J Oral Surg; 1980 Jun; 38(6):412-6. PubMed ID: 6929324
[TBL] [Abstract][Full Text] [Related]
7. [Experimental study of the thrombolytic effectiveness of the fibrinolysin obtained from the euglobulin fraction of donor plasma].
Andreenko GV; Nikiforova TV; Khokhlova RN
Patol Fiziol Eksp Ter; 1974; (1):49-53. PubMed ID: 4282133
[No Abstract] [Full Text] [Related]
8. Effects on fibrin clot lysis of a trypsin inhibitor in peanuts (Arachis hypogaea).
Egeblad K
Thromb Diath Haemorrh; 1967 Feb; 17(1-2):31-41. PubMed ID: 5626247
[No Abstract] [Full Text] [Related]
9. Fibrinolysis and coagulation. I. Effect of calcium on lysis of euglobulin clots.
Helle I
Scand J Haematol; 1967; 4(1):21-32. PubMed ID: 4961989
[No Abstract] [Full Text] [Related]
10. [Thrombolytic action of the enzymatic preparation terrilytin].
Grinberg GE; Mikhaĭlets GA
Probl Gematol Pereliv Krovi; 1972 Sep; 17(9):21-7. PubMed ID: 4668372
[No Abstract] [Full Text] [Related]
11. The euglobulin lysis time: a method for evaluating the plasma fibrinolytic activity of normal and arthritic rats and the therapeutic value of antiinflammatory (steroidal and non-steroidal) agents.
Rüegg M; Riesterer L; Jaques R
Pharmacology; 1970; 4(4):242-54. PubMed ID: 5489998
[No Abstract] [Full Text] [Related]
12. Resistance of porcine blood clots to lysis relates to poor activation of porcine plasminogen by tissue plasminogen activator.
Flight SM; Masci PP; Lavin MF; Gaffney PJ
Blood Coagul Fibrinolysis; 2006 Jul; 17(5):417-20. PubMed ID: 16788320
[TBL] [Abstract][Full Text] [Related]
13. In vivo role of factor XII (Hageman factor) in hypercoagulability and fibrinolysis.
Herold R; Straub PW
J Lab Clin Med; 1972 Mar; 79(3):397-412. PubMed ID: 5061394
[No Abstract] [Full Text] [Related]
14. [Complexes of heparin with antiplasmins and several of their properties].
Pastorova VE; Kudrashov BA; Rodina VI
Vopr Med Khim; 1973; 19(5):492-7. PubMed ID: 4788172
[No Abstract] [Full Text] [Related]
15. [The antithrombotic and thrombolytic activity of tuftsin].
Liapina LA; Pastorova VE; Kondashevskaia MV; Kudriashov BA; Kalikhevich VN; Kamenskiĭ AA; Ashmarin IP
Biull Eksp Biol Med; 1993 Nov; 116(11):451-2. PubMed ID: 8312523
[No Abstract] [Full Text] [Related]
16. Isolated perfusion of pig liver. Effects of reptilase R in hemostasis (author's transl).
Chamone DF; Raia S; Mies S; Jamra M
Rev Bras Pesqui Med Biol; 1974; 7(4):427-33. PubMed ID: 4431989
[No Abstract] [Full Text] [Related]
17. Effects of ellagic acid upon the human fibrinolytic system.
Iatridis SG; Iatridis PG; Ferguson JH
Thromb Diath Haemorrh; 1966 Dec; 16(3):656-67. PubMed ID: 4231538
[No Abstract] [Full Text] [Related]
18. [Controlled experimental study of the relations between fibrinolytic acitivity and anticoagulant activity in evaluation of activators of fibrinolysis].
Cascone A; Lampugnani P
Minerva Med; 1969 Dec; 60(99 Suppl):5039-45. PubMed ID: 4188588
[No Abstract] [Full Text] [Related]
19. Dose dependency of earthworm powder on antithrombotic and fibrinolytic effects.
Kim YS; Pyo MK; Park KM; Hahn BS; Yang KY; Yun-Choi HS
Arch Pharm Res; 1998 Aug; 21(4):374-7. PubMed ID: 9875462
[TBL] [Abstract][Full Text] [Related]
20. Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PA.
Colucci M; D'Aprile AM; Italia A; Gresele P; Morser J; Semeraro N
Thromb Haemost; 2001 Apr; 85(4):661-6. PubMed ID: 11341502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
